Molecular classification and immunologic characteristics of immunoreactive high‐grade serous ovarian cancer
Zheran Liu(Sichuan University), Libin Deng(Nanchang University), Bowen Liang(Sun Yat-sen University), Zixuan Wang(Harbin Institute of Technology), Ailin Yang, Jianyong Li(Jiangsu Province Hospital), Haifang Wu(Nanchang University), Ji Luo(Nanchang University), Yanmei Xu(Nanchang University), Haoqing Wang(Stanford University), Xiaoli Tang(Brown University), F Fu(Nanchang University), Jiachen Deng(Nanchang University)
Cited by 3
Related Papers
Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2015|1.6k
Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: A systematic review and meta-analysis
|Journal of Infection|2020|1.2k
Natural selection on <i>EPAS1</i> ( <i>HIF2α</i> ) associated with low hemoglobin concentration in Tibetan highlanders
|Proceedings of the National Academy of Sciences|2010|854
PD-1/PD-L1 Blockade: Have We Found the Key to Unleash the Antitumor Immune Response?
|Frontiers in Immunology|2017|296